Your browser doesn't support javascript.
loading
The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent.
Xiong, Zuquan; Zang, Yiwen; Zhong, Shan; Zou, Lujia; Wu, Yishuo; Liu, Shenghua; Fang, Zujun; Shen, Zhoujun; Ding, Qiang; Chen, Shanwen.
Afiliação
  • Xiong Z; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Zang Y; Department of General Surgery, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Zhong S; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Zou L; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Wu Y; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Liu S; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Fang Z; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Shen Z; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Ding Q; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Chen S; Department of Urology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
Oncotarget ; 8(18): 30151-30161, 2017 May 02.
Article em En | MEDLINE | ID: mdl-28404914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China